ACCELERATOR
LIVE

Serial Number

98817414

Owner

Thermo Fisher Scientific Inc.

Attorney

Kenya Williams

Filing Date

Oct 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ACCELERATOR Trademark

Serial Number: 98817414

ACCELERATOR is a trademark filed by Thermo Fisher Scientific Inc. on October 23, 2024. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

October 23, 2024

Registration Date

Not Registered

Goods & Services

Software as a service (SAAS) services featuring software for sharing project level clinical research data and project status with clients; Providing temporary use of online nondownloadable software for sharing project level clinical research data and project status with clients; Conducting clinical trials for others; Clinical research and scientific analysis in the fields of pharmaceutical drugs and medical devices; Consulting services in the field of conducting clinical trials; Clinical trial research laboratory analysis services in the fields of pharmaceutical drugs and medical devices; Clinical research in the fields of pharmaceutical drugs and medical devices; Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products, and medical products; Product testing and research in the fields of pharmaceuticals, biopharmaceuticals, health care products, and medical products; Industrial research in the fields of pharmaceuticals, biopharmaceuticals, health care products and medical products; Pharmaceutical and biopharmaceutical drug development services; Pharmaceutical and biopharmaceutical research and development; Product development consultation; Product research services, namely, providing analytical product testing and biosafety product testing for others; Scientific and technical product development for the pharmaceutical industry; Technological consulting and research services in the fields of pharmaceutical drugs and medical devices for the pharmaceutical industry; Custom design and development of chemical reagents and biochemical assays; Providing information technology services, namely, data analytics and data management services in the fields of real world data and real world evidence

Custom manufacturing of pharmaceuticals for use in clinical trials

Consulting services in the field of business management of clinical trials; Supply chain management services for clinical trials

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 5, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 3, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 3, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 5, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 5, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 5, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 26, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 26, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2024 NWOS
NEW APPLICATION ENTERED
Oct 24, 2024 NWAP